INTERFERONS, INTERLEUKIN-2 AND TUMOR-NECROSIS-FACTOR - NEW APPROACHES TO CANCER-THERAPY

被引：0
作者：
OETTGEN, HF
机构：
来源：
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1987年 / 37-1卷 / 2A期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：251 / 255
页数：5
相关论文
共 50 条
[21]   CONCOMITANT ADMINISTRATION OF INTERLEUKIN-2 PLUS TUMOR-NECROSIS-FACTOR IN ADVANCED NONSMALL CELL LUNG-CANCER [J].
SCHILLER, JH ;
MORGANIHRIG, C ;
LEVITT, ML .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (01) :47-51
[22]   COMPLEMENT ACTIVATION AND RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-2, INTERLEUKIN-6 AND SOLUBLE TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-2 RECEPTORS DURING AND AFTER CARDIOPULMONARY BYPASS IN CHILDREN [J].
SAATVEDT, K ;
LINDBERG, H ;
GEIRAN, OR ;
MICHELSEN, S ;
AASEN, AO ;
PEDERSEN, T ;
MOLLNES, TE .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1995, 55 (01) :79-86
[23]   THE CLINICAL-EXPERIENCE WITH INTERLEUKIN-2 IN CANCER-THERAPY [J].
DILLMAN, RO .
CANCER BIOTHERAPY, 1994, 9 (03) :183-209
[24]   PRECLINICAL STUDY OF SEQUENTIAL TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-2 IN THE TREATMENT OF SPONTANEOUS CANINE NEOPLASMS [J].
MOORE, AS ;
THEILEN, GH ;
NEWELL, AD ;
MADEWELL, BR ;
RUDOLF, AR .
CANCER RESEARCH, 1991, 51 (01) :233-238
[25]   INTRAPERITONEAL ADMINISTRATION OF THE BIOLOGIC AGENTS TUMOR-NECROSIS-FACTOR, GAMMA-INTERFERON AND INTERLEUKIN-2 [J].
MARKMAN, M ;
BEREK, JS .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1992, 2 :30-34
[26]   HORSE TROPHOBLASTS PRODUCE TUMOR-NECROSIS-FACTOR A BUT NOT INTERLEUKIN-2, INTERLEUKIN-4, OR INTERFERON-GAMMA [J].
GRUNIG, G ;
ANTCZAK, DF .
BIOLOGY OF REPRODUCTION, 1995, 52 (03) :531-539
[27]   PHASE-I TRIAL OF RECOMBINANT INTERLEUKIN-2 FOLLOWED BY RECOMBINANT TUMOR-NECROSIS-FACTOR IN PATIENTS WITH METASTATIC CANCER [J].
NEGRIER, MS ;
POURREAU, CN ;
PALMER, PA ;
RANCHERE, JY ;
MERCATELLO, A ;
VIENS, P ;
BLAISE, D ;
JASMIN, C ;
MISSET, JL ;
FRANKS, CR ;
MARANINCHI, D ;
PHILIP, T .
JOURNAL OF IMMUNOTHERAPY, 1992, 11 (02) :93-102
[28]   IMMUNOMODULATING THERAPY IN VIRAL MYOCARDITIS - EFFECTS OF TUMOR-NECROSIS-FACTOR, INTERLEUKIN-2 AND ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY IN AN ANIMAL-MODEL [J].
MATSUMORI, A ;
YAMADA, T ;
KAWAI, C .
EUROPEAN HEART JOURNAL, 1991, 12 :203-205
[29]   INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR [J].
HERZOG, C ;
MULLER, W .
ZEITSCHRIFT FUR RHEUMATOLOGIE, 1987, 46 (05) :213-219
[30]   INTERLEUKIN-2, KILLER-CELLS AND CANCER-THERAPY - AN OVERVIEW [J].
PARKINSON, DR ;
LOTZOVA, E .
NATURAL IMMUNITY AND CELL GROWTH REGULATION, 1990, 9 (04) :237-241
12345